Quotient Biodiagnostics Receives FDA License to Sell a Range of Rare Polyclonal Antisera Products in the U.S.A.
10/5/2012 9:47:09 AM
More...
|
Quotient Biodiagnostics Signs 36 Month Agreement With the Premier Healthcare Alliance to Supply Blood Bank Reagents to Its 2,600 Member Hospitals
8/16/2012 9:39:54 AM
More...
|
Quotient Biodiagnostics Raises $11.2 Million of Growth Finance Led by Galen Partners
3/6/2012 7:52:40 AM
More...
|
Quotient Biodiagnostics Receives FDA License to Sell a Full Range of Reagent Red Blood Cell Products in the USA
1/18/2012 11:07:57 AM
More...
|
Quotient Biodiagnostics Receives FDA Clearance To Enter U.S. Transfusion Diagnostics Market
10/19/2009 6:30:30 AM
More...
|